Strategic frame for raising biological and iPo ready
Ankit Aggarwal Is the Director, HealthCare IB, at JP Morgan. To In Biotech, the Capital is lifeline. Scientific progress alone does not bring treatment to patients; Sustainable capital. With a long development period and highlighting period, a biological biological biological…

